Skip to content

Spinal Cord Stimulation for Orthostatic Hypotension

Hemodynamic Effects of Transcutaneous Spinal Cord Stimulation During Passive Orthostasis: a Prospective Single-center Randomized Cross-over Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05230147
Enrollment
20
Registered
2022-02-08
Start date
2022-03-25
Completion date
2024-03-01
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthostatic Hypotension

Keywords

spinal cord stimulation, hypotension, hemodynamic effects

Brief summary

This is a prospective single-center randomized crossover control study that aims to evaluate the effects of non-invasive transcutaneous spinal cord stimulation in patients with known or suspected orthostatic hypotension.

Detailed description

The hypothesis is that transcutaneous spinal cord stimulation at thoracic level may correct hypotensive episodes during tilt testing in subjects with blood pressure drops. Eligible patients will sign an informed consent form before the procedure. Non-invasive transcutaneous electrical stimulation of the spinal cord will be applied using modulated electrical impulses through external adhesive electrode patches connected to a neural stimulator device. The study protocol includes analysis of the following parameters: heart rate; 12-lead electrocardiogram; continuous beat-to-beat blood pressure recordings (measured noninvasively by plethysmography) before stimulation, during stimulation and after spinal cord stimulation. All registered data will be analyzed at the end of the procedure.

Interventions

PROCEDURESpinal cord stimulation

Single stimuli are delivered to define the stimulation threshold. High-frequency stimulation with modulated current via skin patches captures posterior horns of the spinal cord.

PROCEDURESham stimulation

Single stimuli are delivered to define the stimulation threshold. High-frequency stimulation is not delivered.

Sponsors

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Stimulation patches will be applied in all patients and simulating of stimulation will be provided by an audible order by an investigator. Since high-frequency stimulation is almost non-sensible, masking is possible.

Intervention model description

Patients will undergo spinal cord stimulation or a sham procedure during tilt testing following randomization. Then a second test will be performed the same day after crossover. A repeated test will be performed after 7 days in reverse order (sham or stimulation).

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18-85 years 2. Suspected orthostatic hypotension (having a history of syncope and/or pre-syncope that occurred during the transition to an upright position, with complaints of recurrent dizziness that occurs during the transition to an upright position) or documented orthostatic hypotension. 3. The patient who signed the informed consent form

Exclusion criteria

1. Orthostatic hypotension caused by acute hypovolemia or bleeding. 2. Chronic heart failure III-IV functional class (NYHA) 3. Structural heart disease of the following: hypertrophic cardiomyopathy with obstruction of the left ventricular outflow tract, acute coronary syndrome, restrictive cardiomyopathy, hemodynamically significant valvular heart defects, uncorrected hemodynamically significant congenital heart defects. 4. Ongoing acute illness. 5. \>90% paced cardiac rhythm. 6. Permanent atrial fibrillation. 7. A history of transient ischemic attack or stroke within 3 months before the enrollment and/or incomplete recovery. 8. Pulmonary embolism \<1 month ago. 9. Epilepsy. 10. The presence of an implantable pump. 11. Patients with contraindications to the use of the patch electrodes used in this study, as indicated in the relevant instructions for use.

Design outcomes

Primary

MeasureTime frameDescription
Systolic blood pressure drop correction5-30 minutes following verticalizationIt is suggested that spinal cord stimulation will correct systolic blood pressure drop during tilt testing. The effect is expected within 5-10 mmHg as a difference between minimum systolic blood pressure during stimulation and without stimulation (sham).

Secondary

MeasureTime frameDescription
Diastolic blood pressure drop correction5-30 minutes following verticalizationIt is suggested that spinal cord stimulation will correct diastolic blood pressure drop during tilt testing. The effect is expected within 5-10 mmHg as a difference between minimum diastolic blood pressure during stimulation and without stimulation (sham).

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026